Associations between TRAF1-C5 gene polymorphisms and rheumatoid arthritis: A meta-analysis

Immunological Investigations

Volumn 43, Issue 2, 2014, Pages 97-112

  Song, Gwan Gyu ^a   Bae, Sang Cheol ^b   Kim, Jae Hoon ^a   Lee, Young Ho ^a  

^a Korea University College of Medicine   (South Korea)

^b Hanyang University Medical Center   (South Korea)

Author keywords

Meta analysis; Polymorphism; Rheumatoid arthritis; TRAF1 C5

Indexed keywords

COMPLEMENT COMPONENT C5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ALLELE; ARTICLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLEMENT C5; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RISK; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 84893423258     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2013.837917     Document Type: Article

References (47)

1. Barton A, Thomson W, Ke X, et al. (2008). Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Hum Mol Genet, 17, 2274-9.
2. Chang M, Rowland CM, Garcia VE, et al. (2008). A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet, 4, e1000107.
3. Choi SJ, Rho YH, Ji JD, et al. (2006). Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford), 45, 166-70.
4. Criswell LA. (2010). Gene discovery in rheumatoid arthritis highlights the CD40/NF-kappaB signaling pathway in disease pathogenesis. Immunol Rev, 233, 55-61.
5. Danoy P, Wei M, Johanna H, et al. (2011). Association of variants in MMEL1 and CTLA4 with rheumatoid arthritis in the Han Chinese population. Ann Rheum Dis, 70, 1793-7.
6. Davey Smith G, Egger M. (1997). Meta-analyses of randomised controlled trials. Lancet, 350, 1182.
7. Deighton CM, Walker DJ, Griffiths ID, Roberts DF. (1989). The contribution of HLA to rheumatoid arthritis. Clin Genet, 36, 178-82.
8. DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
9. Duval S, Tweedie R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 455-63.
10. Egger M, Davey Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
11. Egger M, Smith GD, Phillips AN. (1997). Meta-analysis: principles and procedures. BMJ, 315, 1533-7.
12. El-Gabalawy HS, Robinson DB, Daha NA, et al. (2011). Non-HLA genes modulate the risk of rheumatoid arthritis associated with HLA-DRB1 in a susceptible North American Native population. Genes Immun, 12, 568-74.
13. Fakhfakh Karray E, Chalbi H, Ben Dhifallah I, et al. (2012). Association study of TRAF1-C5 polymorphism with susceptibility to rheumatoid arthritis in Tunisian population. Joint Bone Spine, 79, 331-2
14. Welcome Trust Case Control Consortium. (2007). Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 661-78.
15. Han TU, Bang SY, Kang C, Bae SC. (2009). TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians. Arthritis Rheum, 60, 2577-84.
16. Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
17. Hikami K, Tsuchiya N, Tokunaga K. (2000). New variations in human OX40 ligand (CD134L) gene. Genes Immun, 1, 521-2.
18. Hinks A, Eyre S, Ke X, et al. (2010). Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis, 69, 1049-53.
19. Julia A, Ballina J, Canete JD, et al. (2008). Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum, 58, 2275-86.
20. Kim HR, Park MK, Cho ML, et al. (2010). Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway. Korean J Intern Med, 25, 317-26.
21. Kurreeman FA, Goulielmos GN, Alizadeh BZ, et al. (2010). The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases. Ann Rheum Dis, 69, 696-9.
22. Kurreeman FA, Padyukov L, Marques RB, et al. (2007). A candidate gene approach identifies the TRAF1-C5 region as a risk factor for rheumatoid arthritis. PLoS Med, 4, e278.
23. Lee YH, Nath SK. (2005). Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet, 118, 434-43.
24. Lee YH, Song GG. (2012). Associations between TNFSF4 and TRAF1-C5 gene polymorphisms and systemic lupus erythematosus: A meta-analysis. Hum Immunol.
25. Lee YH, Witte T, Momot T, et al. (2005). The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. Arthritis Rheum, 52, 3966-74.
26. Lee YH, Rho YH, Choi SJ, et al. (2006). Association of TNF-alpha-308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int, 27, 157-61.
27. MacGregor AJ, Snieder H, Rigby AS, et al. (2000). Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum, 43, 30-7.
28. Mohamed RH, Pasha HF, El-Shahawy EE. (2012). Influence of TRAF1-C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population. Cell Immunol, 273, 67-72.
29. Nath SK, Harley JB, Lee YH. (2005). Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet, 118, 225-34.
30. Nishimoto K, Kochi Y, Ikari K, et al. (2010). Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis, 69, 368-73.
31. Nishimoto K, Kochi Y, Ikari K, et al. (2010). Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis, 69, 368-73.
32. Palomino-Morales RJ, Rojas-Villarraga A, Gonzalez CI, J. (2008). STAT4 but not TRAF1-C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun, 9, 379-82.
33. Patsopoulos NA, Ioannidis JP. (2010). Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis. Ann Rheum Dis, 69, 561-6.
34. Plant D, Flynn E, Mbarek H, et al. (2010). Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis, 69, 1548-53.
35. Plenge RM, Seielstad M, Padyukov L, et al. (2007). TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med, 357, 1199-209.
36. Plenge RM, Padyukov L, Remmers EF, et al. (2005). Replication of putative candidate-gene associations with rheumatoid arthritis in 44, 000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet, 77, 1044-60.
37. Potter C, Eyre S, Cope A, et al. (2007). Investigation of association between the TRAF family genes and RA susceptibility. Ann Rheum Dis, 66, 1322-6.
38. Raychaudhuri S, Remmers EF, Lee AT, et al. (2008). Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet, 40, 1216-23.
39. Schmidt RE, Gessner JE. (2005). Fc receptors and their interaction with complement in autoimmunity. Immunol Lett, 100, 56-67.
40. Stark K, Rovensky J, Blazickova S, et al. (2009). Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls. Arthritis Res Ther, 11, R70.
41. Thomson W, Barton A, Ke X, et al. (2007). Rheumatoid arthritis association at 6q23. Nat Genet, 39, 1431-3.
42. Tsitsikov EN, Laouini D, Dunn IF, et al. (2001). TRAF1 is a negative regulator of TNF signaling. Enhanced TNF signaling in TRAF1-deficient mice. Immunity, 15, 647-57.
43. Wajant H, Henkler F, Scheurich P. (2001). The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal, 13, 389-400.
44. Xu K, Peng H, Zhou M, et al. (2013). Association study of TRAF1-C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythe-matosus: a meta-analysis. Gene, 517, 46-54.
45. Zervou MI, Sidiropoulos P, Petraki E, et al. (2008). Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum Immunol, 69, 567-71.
46. Zhang SQ, Han JW, Sun LD, et al. (2011). A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han population. Rheumatol Int, 31, 227-31.
47. Zhu J, Zhang D, Wu F, et al. (2011). Single nucleotide polymorphisms at the TRAF1-C5 locus are associated with rheumatoid arthritis in a Han Chinese population. BMC Med Genet, 12, 53.